Related Experiment Video
Updated: Jun 19, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Effects of Family-Supported Healthcare on Children with Asthma
Mingyu Shao1, Zhaohong Liu1, Tongtong Liu2
1Department of Child Health Care, Zibo Central Hospital, Zibo, Shandong, 255020, People's Republic of China.
Insights
Family-supported healthcare significantly improves childhood asthma control. This approach enhances pulmonary function, quality of life, and reduces inflammation and hospitalizations in pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Family Medicine
- Public Health
Background:
- Asthma control is crucial for children, but the impact of family support on therapeutic outcomes remains under investigation.
- Understanding the role of family-centered care is essential for optimizing childhood asthma management.
Purpose of the Study:
- To evaluate the effectiveness of family-supported healthcare in improving therapeutic effects for childhood asthma.
- To assess the impact of family support on pulmonary function, asthma control, quality of life, and inflammatory markers in children with asthma.
Main Methods:
- A randomized controlled trial involving pediatric asthma patients divided into control and intervention groups.
- Pulmonary function (FEV1/FVC, FeNO), asthma control, quality of life, and inflammatory cytokines (IL-6, IL-17) were measured.
- Enzyme-linked immunosorbent assay (ELISA) was used to determine cytokine levels.
Main Results:
- The intervention group showed significant improvements in FEV1/FVC and greater reductions in FeNO compared to the control group.
- Family-supported healthcare led to better asthma control, improved quality of life, and significant decreases in IL-6 and IL-17 levels.
- Acute exacerbations and rehospitalization rates were notably lower in the intervention group.
Conclusions:
- Family-supported healthcare is an effective intervention for childhood asthma.
- This approach enhances pulmonary function, improves quality of life, and reduces inflammation, exacerbations, and hospitalizations in pediatric asthma patients.
Introduction:
Healthcare is essential for asthma control, however, whether family-supported healthcare improves therapeutic effects in childhood asthma remains unclear.
Methods:
The enrolled patients were randomly divided into control and intervention groups. The pulmonary function was evaluated by forced expiratory volume in 1 s as a percentage of forced vital capacity (FEV1/FVC) and fractional exhaled nitric oxide (FeNO). Asthma control and life quality were assessed via a childhood asthma control test and pediatric asthma quality of life questionnaire. Inflammatory cytokines interleukin-6 (IL-6) and interleukin-17 (IL-17) were determined by enzyme-linked immunosorbent assay.
Results:
No significant differences existed in the basic characteristics of asthma children and their parents among two groups. The increase of FEV1/FVC was higher in the intervention group versus the control group (76.47 ± 10.76% vs 69.76 ± 8.88%, p = 0.001 at the time of post-intervention), and the decrease of FeNO was greater in the intervention group (30.43 ± 6.85 bbp vs 35.64 ± 6.62 bbp, p = 0.003 at the time of post-intervention). Family-supported healthcare highly improved asthma control and quality of life in childhood asthma post-treatment. Meanwhile, the inflammatory cytokines IL-17 (118.14 ± 25.79 pg/mL in intervention group vs 142.86 ± 28.68 pg/mL in control group, p = 0.004 at the time of post-intervention) and IL-6 (103.76 ± 23.11 pg/mL in intervention group vs 119.73 ± 22.68 pg/mL in control group, p = 0.009 at the time of post-intervention) significantly decreased by family-supported healthcare intervention. Importantly, acute exacerbation (80.8% in intervention group vs 95.7% in control group, p = 0.030) and rehospitalization cases (88.5% in intervention group vs 100% in control group, p = 0.028) also decreased by family-supported healthcare intervention.
Discussion:
Family-supported healthcare improves pulmonary function and quality of life while alleviates inflammation, acute exacerbation, and rehospitalization in childhood asthma post-routine treatment.
Related Concept Videos
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-IV: Nursing Management
First, in...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

